- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by de Meijer, E. P. M.
- Articles by Mandolino, G.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by de Meijer, E. P. M.
- Articles by Mandolino, G.
The Inheritance of Chemical Phenotype in Cannabis sativa L.
Etienne P. M. de Meijer1,a, Manuela Bagattab, Andrea Carbonib, Paola Crucittib, V. M. Cristiana Moliternib, Paolo Ranallib, and Giuseppe Mandolinoba HortaPharm B.V., 1075 VS, Amsterdam, The Netherlands
b Istituto Sperimentale per le Colture Industriali, 40128 Bologna, Italy
Corresponding author: Giuseppe Mandolino, Via di Corticella 133, 40128 Bologna, Italy., g.mandolino{at}isci.it (E-mail)
Communicating editor: C. S. GASSER
| ABSTRACT |
|---|
Four crosses were made between inbred Cannabis sativa plants with pure cannabidiol (CBD) and pure
-9-tetrahydrocannabinol (THC) chemotypes. All the plants belonging to the F1's were analyzed by gas chromatography for cannabinoid composition and constantly found to have a mixed CBD-THC chemotype. Ten individual F1 plants were self-fertilized, and 10 inbred F2 offspring were collected and analyzed. In all cases, a segregation of the three chemotypes (pure CBD, mixed CBD-THC, and pure THC) fitting a 1:2:1 proportion was observed. The CBD/THC ratio was found to be significantly progeny specific and transmitted from each F1 to the F2's derived from it. A model involving one locus, B, with two alleles, BD and BT, is proposed, with the two alleles being codominant. The mixed chemotypes are interpreted as due to the genotype BD/BT at the B locus, while the pure-chemotype plants are due to homozygosity at the B locus (either BD/BD or BT/BT). It is suggested that such codominance is due to the codification by the two alleles for different isoforms of the same synthase, having different specificity for the conversion of the common precursor cannabigerol into CBD or THC, respectively. The F2 segregating groups were used in a bulk segregant analysis of the pooled DNAs for screening RAPD primers; three chemotype-associated markers are described, one of which has been transformed in a sequence-characterized amplified region (SCAR) marker and shows tight linkage to the chemotype and codominance.
CHEMOTYPICAL diversity in Cannabis: The class of secondary products unique to the dioecious species Cannabis sativa L. (hemp) is the terpenophenolic substances known as cannabinoids, which accumulate mainly in the glandular trichomes of the plant (![]()
![]()
![]()
-9-tetrahydrocannabinol (THC). Other common cannabinoids are cannabichromene (CBC; ![]()
-9-tetrahydrocannabivarin (THCV), cannabichromevarin (CBCV), and cannabigerovarin (CBGV), respectively (![]()
![]()
![]()
![]()
![]()
![]()
| The biosynthesis of cannabinoids |
|---|
In the Cannabis plant, cannabinoids are synthesized and accumulated as cannabinoid acids [e.g., cannabidiolic acid (CBDA)]. When the herbal product is dried, stored, or heated, the acids decarboxylize gradually or completely into neutral forms (e.g., CBDA
CBD). For convenience, this article indicates all cannabinoids by the abbreviations for their neutral forms.
The first specific step in cannabinoid biosynthesis is the condensation reaction of geranylpyrophosphate (GPP) with the polyketide, olivetolic acid (OA), which is catalyzed by the enzyme geranylpyrophosphate:olivetolate geranyltransferase (GOT; ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
CBD
THC, was characteristic for fiber strains only. For drug strains, which are often devoid of even trace amounts of CBD, the direct conversion of CBG into THC was supposed to be typical. Today, THC is considered to be derived directly from CBG in all Cannabis strains (Fig 1B); the existence of the postulated enzyme CBD-cyclase catalyzing the synthesis of THC via CBD has not been experimentally confirmed (![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
| Chemotype inheritance |
|---|
There is little doubt that environmental factors have a strong influence in modulating the amount of cannabinoids present in the different parts of the plants at different growth stages, as demonstrated by a number of articles (e.g., ![]()
![]()
![]()
![]()
Quantitative and qualitative aspects of cannabinoid accumulation are often confused as pointed out by ![]()
![]()
![]() |
(1) |
where CYn is the yield of cannabinoid, n (grams per square meter); DM is the total amount of dry, above-ground biomass (grams per square meter); Pflor is the weight proportion of inflorescence leaves and bracts (grams per gram); Ctot is the total cannabinoid content in the inflorescence leaves and bract fraction (grams per gram); and PCn is "purity," the proportion of cannabinoid n in the total cannabinoid fraction (grams per gram).
The first three components determining the cannabinoid yield are probably polygenic traits not related to specific metabolic pathways and are heavily affected by environment. In contrast, the latter term of Equation 1, the proportion of a certain cannabinoid in the total cannabinoid fraction, depends strictly on the metabolic pathways followed by the plant to convert common precursors into specific end products. The focus in this article is on the proportions of the two most commonly found and abundant cannabinoids, CBD and THC, and restricts the definition of chemotype to the ratio of CBD/THC, with both terms expressed as percentage of the inflorescence dry weight.
![]()
![]()
![]()
![]()
![]()
![]()
| DNA markers in Cannabis |
|---|
Today, the concept of Cannabis as a monotypic genus is widely accepted; taxonomical, morphological, and biometrical studies confirm the continuity of its gene pool despite the extremely high variation found within and between populations (![]()
![]()
![]()
![]()
80% of the markers scored, and the data suggested a huge reservoir of variation within even the most selected Cannabis strains considered during the study. Finally, within the dioecious populations, the presence of a high number of male-specific markers, presumably associated with the Y chromosome, was found by RAPD and amplified fragment length polymorphism analysis (![]()
![]()
![]()
| Aim of the work |
|---|
This study aims to clarify the inheritance of cannabinoid chemotype, by isolating pure CBD and pure THC inbred lines. A simple inheritance model was proposed after making crosses between the chemotypically contrasting lines and examining a number of F1 and F2 progenies. An RAPD analysis of the parental lines and their offspring was performed and a number of chemotype-associated markers were described.
| MATERIALS AND METHODS |
|---|
Chemotype assessment:
Mature floral clusters were collected from each and every individual plant. The flower clusters were air dried, and 50 mg of leafy material was weighed in a filtration tube (Ultrafree-CL, 0.1 µm; Millipore, Bedford, MA). The following steps were then repeated four times: 1 ml of ethanol (99.7%) was added, the sample was sonicated in ethanol for 15 min, and the extract was centrifuged at 4000 rpm for 10 min. Then, the total 4 ml of ethanol containing the extracted cannabinoids was transferred from the filtration tube to a 5-ml volumetric flask; 0.25 ml of a phenanthrene stock solution (10 mg/ml in ethanol) was added as internal standard and the volume was adjusted to 5 ml with ethanol. Finally, extracts were homogenized and transferred to GC vials. Gas-chromatographic analyses were performed on a Hewlett-Packard 6890 GC equipped with an autosampler and a flame ionization detector. Two columns were used: the (slightly polar) HP-5, 320 µm x 30 m, with 0.25-µm film for general quantitative analysis of larger sample loads, and the nonpolar HP-1, 100 µm x 40 m, with 0.20-µm film for an accurate separation of CBD from CBC. Average moisture content per progeny studied was determined by drying samples of the floral material at 105° for 3 hr. Moisture correction factors and a linear calibration equation, obtained with a CBD concentration range, were used to convert GC-derived peak areas to dry weight concentrations. Compound identities were determined by matching retention times with those of pure standards.
Constitution of inbred lines:
All parentals used in this study were doubly inbred plants (S2's) obtained through the self-fertilization of selected female clones from the Cannabis collection of HortaPharm B.V., The Netherlands. The original plants had either CBD or THC as the predominant cannabinoid. The 00.45.1 clone was an exception, having both CBD and THC in similar amounts. The clones were obtained through in vivo propagation of lateral branches. An individual from each clone was partially sex reversed according to the procedure described by ![]()
|
Production of F1's and F2's:
Seven individual plants belonging to the six S2 lines with contrasting chemotypes were chosen to produce hybrid F1's. The individual female plants used as pollen parents were partially sex reversed and placed in isolation cabinets with the seed parent plants. The crosses performed are summarized in Table 2.
|
The next season, a variable number of individual plants of the four different F1's were grown and their chemotype was determined. Again, leaf samples from 520 plants belonging to the four F1's were taken for molecular analysis. Ten F1 plants (3 plants from cross 99.3, 3 from 99.4, 1 from 99.5, and 3 from 99.6; Table 2) were again treated to obtain partial sex reversion, isolated, and allowed to set F2 seed. The seeds were sown and a variable number of F2 mature plants, ranging from 35 to 118, were evaluated for chemotype; leaf samples were again collected for DNA analysis. During three seasons (19982000), the complete cycle from the parental S2 inbred lines to the different F2 progenies was accomplished under similar greenhouse conditions and strict isolation. Confirmation of the genetic femaleness of all the plants was based on the absence of any male-specific marker.
Molecular analysis:
From each leaf sample taken from S2, F1, and F2 individual plants, genomic DNA was prepared using the Nucleon Phytopure kit (Amersham Pharmacia Biotech, Buckinghamshire, UK). The DNA concentration of each sample was adjusted to 1 µg/µl after 260-nm readings, and 20 ng were used for amplification reactions. RAPD analysis using decamer primers of random sequence (purchased from Operon Technologies, Alameda, CA, and the Nucleic Acid-Protein Service Unit, Biotechnology Laboratory, University of British Columbia, Canada) and gel electrophoresis were conducted as described elsewhere (![]()
![]()
-32P]dCTP according to ![]()
![]()
![]()
| RESULTS |
|---|
Variation in cannabinoid composition:
Examples of Cannabis gas-chromatographic profiles are shown in Fig 1A. The variation found within accessions is usually at both levels of cannabinoid type (different retention times) and amount (different peak areas), confirming other authors' observations (![]()
![]()
S2 inbred lines:
If the clone originally used to produce the S2 was of a pure CBD or THC chemotype, this chemotype is preserved throughout all the subsequent inbred generations, although the absolute amount of the dominant cannabinoid still shows considerable variation, as demonstrated by the standard deviations found (Table 1).
The molecular analysis performed on the S2 lines suggested a narrowing of the genetic variation within these materials, especially if compared with noninbred populations as examined previously (![]()
![]()
F1 hybrids:
When the S2 plants were mutually crossed as indicated in Table 2, all F1 plants examined contained both CBD and THC in considerable amounts, and no pure chemotypes were found. An example of the distribution of the F1 plants (F1 99.3) in a CBD vs. THC plot is presented in Fig 2, where the values for the parental plants are also indicated. Fig 2 shows a heterotic effect for the total cannabinoid content (CBD + THC) and in particular a strong increase of the CBD content of the F1's as compared with the parental CBD content. Similar patterns were found in two of the other F1's. However, there was no such effect on the total cannabinoid content in the 99.4 F1.
|
Surprisingly, the CBD/THC ratio appeared to vary in a clear progeny-specific way. The average ratio varied significantly (P < 0.001) from 0.50 (F1 99.4) up to 1.57 (F1 99.5), where only four plants could be analyzed (Table 3).
|
The molecular analysis of the F1 plants was again carried out by using three RAPD primers and comparing the loci identified in the parental plants with those present in the F1 progenies. In the four progenies, from 5.6% (99.3) to 37.5% (99.4) of the RAPD loci scored in the parental plants segregated in the F1 (data not shown). This indicates that a still significant number of loci were in the heterozygous state in the S2 parentals.
F2 inbreds:
The CBD vs. THC contents of one of the F2's examined are plotted in Fig 3. Within each F2, the individuals could unmistakably be assigned to three different segregant groups on the basis of large discontinuities in the calculated CBD/THC ratios. Data on the segregation of chemotypes in the different F2's are shown in Table 4. For all F2's, the results of the
2 test accepted the model of a single locus with two codominant alleles. In those F2's where the segregation ratios deviated most from 1:2:1 (largest
2 values), this was consistently due to an underrepresentation of pure CBD chemotypes.
|
|
As in the F1's, the CBD/THC ratio for heterozygous plants in the F2's again appeared to be strongly progeny dependent. ANOVA and a multiple-comparison least-squared difference (LSD) test performed on heterozygous CBD/THC ratios of all evaluated F1 and F2 progenies showed highly significant differences among progenies (P < 0.001; Table 3). Especially, the 99.4 progenies form a very distinct cluster as they are composed of heterozygotes having a much higher proportion of THC than of CBD. In all other progenies the proportion of CBD in heterozygotes exceeds, to a varying extent, the THC proportion. Small, though significant, differences in mean CBD/THC ratio do occur among progenies sharing the same pedigree. However, the F1 CBD/THC ratios (assessed in a different year from the F2 ratios) are transmitted with very little change to the heterozygotes of the corresponding inbred F2's.
Molecular markers associated to chemotype:
The clear-cut segregation observed in all the F2's considered allowed the application of the bulk segregant analysis (BSA; ![]()
400 bands were scored. In several cases, bands discriminating one or more of the bulks were observed, but only three primers, OPA07 (5'-GAAACGGGTG-3') and OPB06 (5'-TGCTCTGCCC-3') from Operon Technologies and UBC109 (5'-TGTACGTGAC-3') from the University of British Columbia, produced three bands, two THC and one CBD associated, discriminating six or seven pairs of DNA bulks. The CBD-associated band (UBC109620) was
620 bp, while the two THC-associated markers (OPB061000 and OPA072100) were
1000 and 2100 bp. The RAPD bands discriminating the chemotypes within each bulk are shown in Fig 4, ac. The chemotype-associated bands were then examined in the single-plant DNAs comprising the bulks. The results are summarized in Table 5. Marker OPA072100 appeared to be the most effective as it is present in all THC plants and in only 2 out of 61 CBD plants examined. Marker OPB061000 is equally effective for THC plants, but it was detected in 6 out of 61 CBD plants as well. Marker UBC109620, CBD associated, is present in all CBD F2's except 99.5.5, where only 1 plant out of 9 consistently showed the marker. The same marker is also present in 12 out of 61 THC plants examined. In general, if lack of association can be attributed to genetic recombination between the chemotype locus and the marker, then the marker OPA072100 had 1.3% recombination, marker OPB061000 had 5.3%, and marker UBC109620 had
10.3%, calculated as average of all the seven F2's.
|
|
The three markers were sequenced and different combinations of 20-mer specific primers were constructed on the basis of the DNA sequence and tested. The best primers were found to be derived from the marker OPB061000, originally THC associated. This sequence-characterized amplified region (SCAR) marker, termed B190/B200, was tested on all single plants of the F2's examined, pure THC, pure CBD, or heterozygous CBD/THC, and on all the S2 plants from the original cross parents. The result of DNA amplification primed by B190/B200 primers (forward, 5'-TGCTCTGCCCAAAGTATCAA-3'; reverse, 5'-CCACTCACCACTCCACCTTT-3') is shown in Fig 4D. The THC phenotype is associated with the amplification of a band of approximate molecular weight of 190 bp, whereas pure CBD plants show a band of
200 bp. Heterozygous plants showed both fragments in most cases, indicating that this marker had the same codominance characteristics as the chemotype locus; these plants also showed an additional band at higher molecular weight (
250 bp). The efficiency of the B190/B200 marker in predicting the chemotype of the plants examined in this work is summarized in Table 6. Remarkably, the efficiency with which the concurrent appearance of both markers identified the heterozygous chemotypes is 95.3%. These values were calculated on the basis of the results of the markers in 63 plants belonging to the S2 inbred lines, in 39 plants from the four different F1's, and in 246 plants of the different F2's. The sequenced portions of the DNA fragments generated by the RAPD primers were found to share no significant homology with the published DNA sequences for the THC and CBD synthases (GenBank nos. E55108/GI 18629739 and E33091/ GI 18623981; patent pending).
|
| DISCUSSION |
|---|
Within Cannabis populations, large variations in cannabinoid composition and content can be found among individual plants. Therefore, to study the inheritance of the chemotype trait, we chose to use inbred, female lines with fixed, pure chemotype. RAPD data confirmed the relative narrowing of the genetic basis of the parental plants due to this strategy (Table 1). In the parental S2 lines, the percentage of the major cannabinoid (PCn) ranged from 84 to 98% of the total cannabinoid fraction Ctot. For the F1 99.3, 99.5, and 99.6 and for their F2 offspring, the sum of CBD and THC reached proportions of 95% of Ctot. The remaining fractions were composed of varying mixtures of CBG, CBC, THCV, and CBDV. The 99.4 F1's and their F2 descendants had a lower proportion of CBD + THC (91%). This was due to a consistent presence of higher amounts of CBG, a feature inherited from both parents of this progeny.
The uniformity of F1 chemotypes and the F2 segregation ratios demonstrate the presence of a single locus, which is referred to as B, showing simple Mendelian inheritance of the two alleles, BD and BT, evidenced by this study. The model proposes that a pure CBD plant has a BD/BD genotype at the B locus, while a pure THC plant has a BT/BT genotype. F1 and
50% of the F2 plants are therefore heterozygous BD/BT, with the two alleles being codominant and therefore simultaneously expressed in the hybrids. The hypothesis of two alleles at one locus was accepted by
2 tests for all the F2's examined (Table 4). This model agrees with the assumption of a monogenic inheritance as expressed by ![]()
It should be acknowledged that these results may also be explained with the hypothesis of two duplicated loci, one encoding for a CBD synthase and the other for a THC synthase, mapping so closely that observation of linkage rupture was impossible in the progenies examined. Such a situation was found in different cases of secondary metabolism genes where duplicated members encoded for enzymes catalyzing either consecutive metabolic steps or alternative reactions from a common precursor. In maize, a family of four duplicated genes (BX25) was shown to encode for cytochrome P450-dependent monooxygenases, each catalyzing one of the consecutive steps from indole to 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) synthesis (![]()
![]()
![]()
![]()
These facts are more convincingly explained by the rare occurrence of a mutated B0 allele for a defective enzyme at a single locus. ![]()
Although based on negative evidence, it is our opinion that the model of a single allelic locus governing the synthesis of CBD and THC better explains the chemotype distribution in Cannabis populations.
In those F2's where the segregation ratios deviated most from 1:2:1 (largest
2 values), this was consistently due to an underrepresentation of CBD homozygotes, possibly an effect of a recessive semilethal factor loosely associated with the BD allele. For the 99.3.34 F2, differential seed viability and seedling survival could explain the lower proportion of CBD homozygotes. The other F2's with higher
2 values showed an insignificant loss of seeds and seedlings. The assumed semilethal factor in these progenies must therefore already be effective during embryogenesis. An additional indication of reduced viability of the BD /BD genotype is provided by the dramatic drop of fertility in pure CBD plants during line selection, a phenomenon that is usually absent in THC inbreds (data not shown). Although one can expect most fiber cultivars to have the BD/BD genotype, to the best of our knowledge there are no reports on reduced viability and fertility of such strains, as compared with high-THC populations. However, only a chemotypically segregating population could provide proper evidence for such a phenomenon, as all other genetic traits contributing to viability and fertility need to be randomized among chemotype groups.
In three out of the four F1 progenies, the CBD content was higher than in the CBD parental (Fig 2). This can be explained by the fact that CBD parental lines, usually derived from fiber strains, have low values for Pflor and Ctot (see Equation 1). These components, polygenic in nature, show a strong heterotic effect; therefore, the BD allele of F1 plants is active in a much more productive genetic environment than that in the parental lines. This does not hold true for the BT allele, which already comes from drug strains with high Pflor and Ctot values.
When working with young, vegetative plant materials, the molecular markers described may be more effective than GC chromatograms in genotyping plants for their chemotype. The RAPD markers originally identified were completely dominant, as expected from a PCR marker; however, the marker B190/B200, one of the SCAR markers developed on the basis of sequence information, behaves codominantly (Fig 4D). Both types of marker appear tightly linked to the chemotype in the pedigrees so far examined (Table 5 and Table 6). The B190/B200 marker could be profitably employed in the breeding work, though at present we have no data on its utility beyond the specific crosses made in this study. The marker seems particularly suitable to distinguish pure CBD and heterozygous plants, which can be valuable when counterselecting for THC chemotypes in fiber hemp breeding.
The synthesis of THC and CBD in Cannabis plants has been described as an oxidoreduction coupled to a cyclization of CBG, catalyzed by a THC and a CBD synthase, respectively. A CBC synthase has also been described, catalyzing a similar reaction leading to CBC. These enzymes were isolated from different drug or fiber strains, and many of their characteristics were elucidated. Most of the properties of CBD and THC synthase were very similar, like the mass (75 kD), the existence as a monomer localized in the cytosol, the pI, the optimum pH, the rate constant kcat, the Vmax, and the Km for their substrate. Also, the NH2-terminal sequence of the two synthases shared 87% of identity (![]()
![]()
![]()
![]()
![]()
The data obtained in this work do not take into account the inheritance of the conversion of CBG into CBC. In principle, it is possible to suppose the existence of a further allele, BC, at the B locus, coding for a CBC synthase (![]()
![]()
The model for the biogenesis of cannabinoids with its relations between alleles and resulting chemotypes is illustrated in Fig 5. In this scheme, it is assumed that the pathway leading to CBG or CBGV is governed by at least one allelic locus, called A, on which the experiments presented here provide no information. However, there is evidence for the existence of "null" genotypes at the A locus, leading to plants devoid of any cannabinoids; such phenotypes have indeed been observed (V. G. VIROVETS and G. GRASSI, personal communication). The pathways shown are consistent with the assumption of ![]()
|
In the materials studied, the proportions of both CBD and THC reached at best
9698% of the total cannabinoid fraction. Generally, even after five cycles of inbreeding selection aimed at one target cannabinoid, at least a 24% impurity consisting of other cannabinoids remains. Therefore, the alleles postulated here, even in homozygous genotypes, seem to have an imperfect control over the biosynthetic events. Apparently, any of the postulated isoenzymatic forms encoded by the alleles at the B locus show a residual ability to convert the precursor CBG(V) into cannabinoids other than the major one.
The existence of a single locus determining the chemotype, with at least two alleles, gives a clear genetic meaning to the tripartite distribution of the chemotypes within populations, as observed by several authors when CBD vs. THC content plots are considered (![]()
![]()
![]()
In the work presented here, the strategy of partial sex reversion of female plants was used to obtain S2, F1's, and F2's; yet the results obtained are also expected to hold true if dioecious plants had been used as parentals or F1 plants had been intercrossed to obtain segregating F2's. The model proposed here is therefore highly predictive and intended to stimulate further research: it provides a tool to elucidate the possible existence of other genetic loci regulating the cannabinoid composition.
| FOOTNOTES |
|---|
1 Present address: GW Pharmaceuticals plc., Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, United Kingdom. ![]()
| ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge the plant breeding and chemical-analytical assistance of Tina Ent (Horta Pharm B.V.) and Kathy Hammond (GW Pharmaceuticals plc.) for text revision. This work was funded in part by the Italian Ministry of Agriculture and Forestry in the framework of the project "Induction of phenotypic markers and improvement of common hemp."
Manuscript received April 23, 2002; Accepted for publication October 16, 2002.
| LITERATURE CITED |
|---|
BECU, D. M. S., H. D. MASTEBROEK and H. J. P. MARVIN, 1998 Breeding for root knot nematode resistance in hemp. Proceedings of Bast Fibrous Plants Today and Tomorrow, St. Petersburg, Russia, p. 149.
BEUTLER, J. A. and A. H. DER MANDEROSIAN, 1978 Chemotaxonomy of Cannabis I. Crossbreeding between Cannabis sativa and C. ruderalis, with analysis of cannabinoid content. Econ. Bot. 32:387-394.
BÓCSA, I., P. MATHÉ, and L. HANGYEL, 1997 Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L.) leaves at different positions. J. Int. Hemp Assoc. 4:80-81.
DE MEIJER, E. P. M. and L. C. P. KEIZER, 1996 Patterns of diversity in Cannabis.. Genet. Res. Crop Evol. 43:41-52.
DE MEIJER, E. P. M., H. J. VAN DER KAMP, and F. A. VAN EEUWIJK, 1992 Characterisation of Cannabis accessions with regard to cannabinoid content in relation to other plant characters. Euphytica 62:187-200.
DE ZEEUW, R. A., TH. M. MALINGRE, and F. W. H. M. MERKUS, 1972a Tetrahydrocannabinolic acid, an important component in the evaluation of Cannabis products. J. Pharm. Pharmacol. 24:1-6.[Medline]
DE ZEEUW, R. A., J. WIJSBEK, D. D. BREIMER, T. B. VREE, and C. A. VAN GINNEKEN et al., 1972b Cannabinoids with a propyl side chain in Cannabis. Occurrence and chromatographic behaviour. Science 175:778-779.
FAETI, V., G. MANDOLINO, and P. RANALLI, 1996 Genetic diversity of Cannabis sativa germplasm based on RAPD markers. Plant Breed. 115:367-370.
FEINBERG, A. P. and B. VOGELSTEIN, 1983 A technique for radiolabeling DNA restriction endonuclease fragments to high specific activities. Anal. Biochem. 132:6-13.[Medline]
FELLERMEIER, M. and M. H. ZENK, 1998 Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. FEBS Lett. 427:283-285.[Medline]
FELLERMEIER, M., W. EISENREICH, A. BACHER, and M. H. ZENK, 2001 Biosynthesis of cannabinoids. Incorporation experiments with 13C-labeled glucoses. Eur. J. Biochem. 268:1596-1604.[Medline]
FLACHOWSKY, H., E. SCHUMANN, W. E. WEBER, and A. PEIL, 2001 Application of AFLP for the detection of sex-specific markers in hemp. Plant Breed. 120:305-309.
FORAPANI, S., A. CARBONI, C. PAOLETTI, V. M. C. MOLITERNI, and P. RANALLI et al., 2001 Comparison of hemp (Cannabis sativa L.) varieties using RAPD markers. Crop Sci. 41:1682-1689.
FOURNIER, G., 1981 Les chemiotypes du chanvre (Cannabis sativa L.). Intérêt pour un programme de sélection. Agronomie 1:679-688.
FOURNIER, G. and M. R. PARIS, 1979 Le chanvre papetier (Cannabis sativa L.) cultivé en France: le point sur ses constituants. Plant. Med. Phytother. 13:116-121.
FOURNIER, G. and M. PARIS, 1980 Détermination de chimiotypes à partir des cannabinoïdes chez le chanvre à fibres monoïque (Cannabis sativa L.). Possibilités de sélection. Physiol. Veg. 18:349-356.
FOURNIER, G., C. RICHEZ-DUMANOIS, J. DUVEZIN, J.-P. MATHIEU, and M. PARIS, 1987 Identification of a new chemotype in Cannabis sativa: cannabigerol-dominant plants, biogenetic and agronomic prospects. Plant. Med. 53:277-280.
FREY, M., R. KLEIM, H. SAEDLER, and A. GIERL, 1995 Expression of a cytochrome P450 gene family in maize. Mol. Gen. Genet. 246:100-109.[Medline]
GAONI, Y. and R. MECHOULAM, 1966 Cannabichromene, a new active principle in hashish. Chem. Commun. 1:20-21.
GLAWISCHNIG, E., S. GRÜN, M. FREY, and A. GIERL, 1999 Cytochrome P450 monooxygenases of DIBOA biosynthesis: specificity and conservation among grasses. Phytochemistry 50:925-930.[Medline]
HAMMOND, C. T. and P. G. MAHLBERG, 1977 Morphogenesis of capitate glandular hairs of Cannabis sativa (Cannabaceae). Am. J. Bot. 64:1023-1031.
HILLIG, K., 2002 Letter to the editor. J. Ind. Hemp 7:5-6.
HOLLEY, J. H., K. W. HADLEY, and C. E. TURNER, 1975 Constituents of Cannabis sativa L. XI. Cannabidiol and cannabichromene in samples of known geographical origin. J. Pharm. Sci. 64:892-894.[Medline]
HORKAY, E., 1986 Establishing the share of self- and cross fertilisation by means of population genetics in a monoecious hemp stand. Növénytermelés 35:177-182. (in Hungarian).
KLIEBENSTEIN, D. J., V. M. LAMBRIX, M. REICHELT, J. GERSHENZON, and T. MITCHELL-OLDS, 2001 Gene duplication in the diversification of secondary metabolism: tandem 2-oxoglutarate-dependent dioxygenases control glucosinolate biosynthesis in Arabidopsis.. Plant Cell 13:681-693.
LYDON, J., A. H. TERAMURA, and C. B. COFFMAN, 1987 UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes. Photochem. Photobiol. 46:201-206.[Medline]
MANDOLINO, G., A. CARBONI, S. FORAPANI, V. FAETI, and P. RANALLI, 1999 Identification of DNA markers linked to the male sex in dioecious hemp (Cannabis sativa L.). Theor. Appl. Genet. 98:86-92.
MANDOLINO, G., A. CARBONI, M. BAGATTA, V. M. C. MOLITERNI, and P. RANALLI, 2002 Occurrence and frequency of putatively Y chromosome linked DNA markers in Cannabis sativa L. Euphytica 126:211-218.
MECHOULAM, R., 1970 Marijuana chemistry. Science 168:1159-1166.
MICHELMORE, R. W., I. PARAN, and R. V. KESSELI, 1991 Identification of markers linked to disease-resistance genes by bulked segregant analysis: a rapid method to detect markers in specific genomic regions by using segregating populations. Proc. Natl. Acad. Sci. USA 88:9828-9832.
MOHAN RAM, H. Y. and R. SETT, 1982 Induction of fertile male flowers in genetically female Cannabis sativa plants by silver nitrate and silver thiosulphate anionic complex. Theor. Appl. Genet. 62:369-375.
MORIMOTO, S., K. KOMATSU, F. TAURA, and Y. SHOYAMA, 1997 Enzymological evidence for cannabichromenic acid biosynthesis. J. Nat. Prod. 60:854-857.
MORIMOTO, S., K. KOMATSU, F. TAURA, and Y. SHOYAMA, 1998 Purification and characterization of cannabichromenic acid synthase from Cannabis sativa.. Phytochemistry 49:1525-1529.[Medline]
SHOYAMA, Y., M. YAGI, and I. NISHIOKA, 1974 Biosynthesis of cannabinoid acids. Phytochemistry 14:2189-2192.
SHOYAMA, Y., H. HIRANO, and I. NISHIOKA, 1984 Biosynthesis of propyl cannabinoid acid and its biosynthetic relationship with pentyl and methyl cannabinoid acids. Phytochemistry 23:1909-1912.
SMALL, E. and H. D. BECKSTEAD, 1973 Common cannabinoid phenotypes in 350 stocks of Cannabis.. Lloydia 36:144-165.[Medline]
SMALL, E., P. Y. JUI, and L. P. LEFKOVITCH, 1976 A numerical taxonomy analysis of Cannabis with special reference to species delimitation. Syst. Bot. 1:67-84.
SYTNIK, V. P. and A. F. STELMAH, 1999 The character of inheritance of differences in cannabinoid content in hemp (Cannabis sativa L.). J. Ind. Hemp Assoc. 6:8-9.
TAURA, F., S. MORIMOTO, and Y. SHOYAMA, 1995 First direct evidence for the mechanism of delta-1-tetrahydrocannabinolic acid biosynthesis. J. Am. Chem. Soc. 38:9766-9767.
TAURA, F., S. MORIMOTO, and Y. SHOYAMA, 1996 Purification and characterization of cannabidiolic-acid synthase from Cannabis sativa L. J. Biol. Chem. 271:17411-17416.
YOTORIYAMA, M., I. ITO, D. TAKASHIMA, Y. SHOYAMA, and I. NISHIOKA, 1980 Breeding of Cannabis. Determination of cannabinoids by high-pressure liquid chromatography. Yakugaku Zasshi 100:611-614.[Medline]
This article has been cited by other articles:





